Jonathan S Leff Net Worth

The estimated Net Worth of Jonathan S Leff is at least $4.26 Milhão dollars as of 30 May 2007. Jonathan Leff owns over 677,200 units of BiomX Inc stock worth over $4,261,034 and over the last 19 years Jonathan sold PHGE stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Jonathan Leff PHGE stock SEC Form 4 insiders trading

Jonathan has made over 3 trades of the BiomX Inc stock since 2005, according to the Form 4 filled with the SEC. Most recently Jonathan bought 677,200 units of PHGE stock worth $2,999,996 on 30 May 2007.

The largest trade Jonathan's ever made was buying 805,153 units of BiomX Inc stock on 17 March 2006 worth over $5,000,000. On average, Jonathan trades about 192,735 units every 61 days since 2005. As of 30 May 2007 Jonathan still owns at least 4,304,075 units of BiomX Inc stock.

You can see the complete history of Jonathan Leff stock trades at the bottom of the page.

What's Jonathan Leff's mailing address?

Jonathan's mailing address filed with the SEC is C/O BIOMX INC., 22 EINSTEIN ST., FLOOR 4, , NESS ZIONA,, L3, 7414003.

Insiders trading at BiomX Inc

Over the last 5 years, insiders at BiomX Inc have traded over $332,366 worth of BiomX Inc stock and bought 1,036,414 units worth $787,614 . The most active insiders traders include James Edeerfield Management..., Chidozie Ugwumba, eErez Chimovits. On average, BiomX Inc executives and independent directors trade stock every 68 days with the average trade being worth of $533,749. The most recent stock trade was executed by James Edeerfield Management... on 15 July 2024, trading 11,766,000 units of PHGE stock currently worth $11,648,340.

What does BiomX Inc do?

biomx is a microbiome drug discovery company developing customized phage therapies that target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease (ibd) and cancer. we discover and validate proprietary bacterial targets and customize our natural and engineered phage compositions against these targets. the company’s platforms use computational and synthetic biology and cutting-edge research from profs. rotem sorek, ph.d., eran elinav, m.d., ph.d., and eran segal, ph.d., of the weizmann institute of science; and professor timothy k. lu, m.d., ph.d., of the massachusetts institute of technology. investors in the company include orbimed israel incubator lp, johnson & johnson development corporation inc., takeda ventures, inc., seventure partners, mirae asset global investments, and sbi.

Complete history of Jonathan Leff stock trades at Sunesis Pharmaceuticals Inc e BiomX Inc

BiomX Inc executives and stock owners

BiomX Inc executives and other stock owners filed with the SEC include:

• Jonathan Solomon,
  Chief Executive Officer, Director
• Sailaja Puttagunta,
  Chief Medical Officer
• Assaf Oron,
  Chief Business Officer
• Dr. Merav Bassan Ph.D.,
  Chief Devel. Officer
• Russell Greig,
  Independent Chairman of the Board
• Lynne Sullivan,
  Independent Director
• Paul Sekhri,
  Independent Director
• Alan Moses,
  Independent Director
• Jonas Grossman,
  Independent Director
• Gbola Amusa,
  Independent Director
• Merav Bassan,
  Chief Development Officer
• Marina Wolfson,
  Principal Financial Officer, Vice President - Finance and Operations
• Dr. Regis A. Vilchez M.D., Ph.D.,
  Sr. VP & Head of Clinical Devel.
• Dr. Inbar Gahali-Sass,
  VP of Platform R&D
• Dr. Timothy K. Lu M.D., Ph.D.,
  Scientific Founder
• Dr. Eran Elinav M.D., Ph.D.,
  Scientific Founder
• Inbal Benjamini-Elran,
  VP of HR
• Noel Kurdi,
  VP of Investor Relations & Strategy
• Prof. Timothy K. Lu,
  Scientific Founder
• Dr. Eran Elinav,
  Scientific Founder
• Prof. Rotem Sorek Ph.D.,
  Scientific Founder
• Assaf Oron,
  Chief Bus. Officer
• Yaron Breski,
  Director
• Erez Chimovits,
  Director
• Thomas Layton Walton,
  10% owner
• Eddie Williams,
  Director
• Kerry Mountain Wood Llc Pro...,
  
• Israel Bio Fund Gp Limited ...,
  
• Chidozie Ugwumba,
  
• Susan Blum,
  Director
• Gregory Louis Merril,
  Director
• Jonathan S Leff,
  Director
• Jesse Goodman,
  Director
• James Edeerfield Management...,
  
• Israel Bio Fund Gp Limited ...,
  
• James Edeerfield Management...,
  
• Jason M. Marks,
  Director
• Michael E. Dambach,
  Director
• Fibrosis Foundation Cystic,